← Scoopfeeds — Intelligent news, curated.
This $250 Million Startup Tracks How Cancer Reacts To Treatment In Real Time
business

This $250 Million Startup Tracks How Cancer Reacts To Treatment In Real Time

Forbes · May 13, 2026, 10:00 AM · Also reported by 1 other source

NVision raises $38 million led by health diagnostics giant Abbott to scale up its groundbreaking cancer imaging system. Next up: using its quantum technology to design new drugs.

Read full story on Forbes → More top stories

Also covered by

DW English The sea that is vanishing in real time

More in business

Investing.com
German court rules Milka chocolate bar weight cut misleading
Investing.com
Trump’s designs on Greenland prod investment, tourism likely to pay off faster than mines
Investing.com
Argus cuts Constellation Energy stock price target on valuation
Investing.com
Argus raises New York Times stock price target to $88 on digital growth
Investing.com
Argus raises First Solar stock price target to $275 on trade position
Aggregated and edited by the Scoop newsroom. We surface news from Forbes alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop